Long QT Syndrome: Clinical Trials

5 trials for Long QT Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Unknown 1

Follow Long QT Syndrome: new trials by email Literature Review of Long QT Syndrome trials Research Report on Long QT Syndrome

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diltiazem in Jervell and Lange-Nielsen Syndrome
diltiazem - Jervell and Lange Nielsen Syndrome
Phase 4CompletedVanderbilt University Medical Center12024-10-162025-10-14
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced
Phase 4CompletedIndiana University732021-09-022026-10-20
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
Progesterone, Ibutilide - Long QT Syndrome, Abnormalities, Drug-Induced
Phase 4CompletedIndiana University272019-03-262025-07-01
Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
Testosterone, Progesterone, Placebo - Long QT Syndrome
Phase 4CompletedIndiana University142016-05-012019-08-28
Novel Form of Acquired Long QT Syndrome
Prednisone - Long QT Syndrome, Connective Tissue Diseases
Phase 4UnknownNarrows Institute for Biomedical Research252011-09-282022-04-11

Narrower conditions

Abnormalities, Drug-Induced (2)  ·  Arthritis, Rheumatoid (1)  ·  Connective Tissue Diseases (1)  ·  Jervell-Lange Nielsen Syndrome (1)  ·  Risk Reduction Behavior (1)  ·  Torsades de Pointes (1)

Broader conditions

Arrhythmias, Cardiac (5)  ·  Cardiac Conduction System Disease (5)  ·  Cardiovascular Abnormalities (5)  ·  Cardiovascular Diseases (5)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Heart Defects, Congenital (5)  ·  Heart Diseases (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Behavior (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)

Interventions

Progesterone (3)  ·  ibutilide (3)  ·  Testosterone (2)  ·  Diltiazem (1)  ·  Drugs, Generic (1)  ·  Lactose (1)  ·  Prednisone (1)

Sponsors

Indiana University (3)  ·  Narrows Institute for Biomedical Research (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (5)

Top investigators

James E Tisdale, PharmD (3)  ·  Prince J Kannankeril, MD, MSCI (1)

Results publications

PMID 33020898

NIH funding

R01HL153114 (1)